Biotechnology
Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development
HONG KONG, Germantown, Md. and SUZHOU, China, July 28, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced tha...
2023-07-28 11:56
1977
Nutromics attracts world leaders in the emerging field of DNA-based sensing to join its Biosensor Advisory Board
MELBOURNE, Australia, July 28, 2023 /PRNewswire/ -- Nutromics has announced today that its lab-on-a-patch technology has attracted the support of multiple world-class experts from leading US and Australian institutions, who now comprise its Biosensor Advisory Board. Nutromics is a leader in conti...
2023-07-28 08:27
1680
Frost & Sullivan Awarded Duopharma Biotech with the 2022 Malaysian Company of the Year Award
Duopharma Biotech is the first pharmaceutical company to offer biosimilar products in the Malaysian market. SAN ANTONIO, July 27, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian biosimilars industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...
2023-07-27 14:00
1386
Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress
TAIZHOU, China, July 27, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the"Board") is pleased to announce that the Group has recently received the notice of acceptance (acceptance number: CXSL2300518) issued by National Medical Products Administration ("NMPA"), pursuant to which the c...
2023-07-27 10:57
3839
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China
Everest transforms into a commercial-stage innovative biopharmaceutical company SHANGHAI, July 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicin...
2023-07-27 08:10
1794
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
Total revenues increase by 36.3% year-over-year; gross margin improves to 77.7%; balance sheet remains robust Company's PIKA rabies vaccine approved for Phase III clinical trials in Singapore, the Philippines, and Pakistan; interim results expected early next year GAITHERSBURG, Md., July 27, 20...
2023-07-27 05:00
4147
Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development
* Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung cancer and patients with genetic aberrations in HER3 signaling * Hummingbird Bioscience has identified genetic signatures that are predictive of response t...
2023-07-27 04:00
1714
How MGI Boosts Agrigenomics and Food Sustainability with Sequencing Technology: An Australian Case Study
PERTH, Australia, July 26, 2023 /PRNewswire/ -- In the wake of the recent UN Food Systems +2 Stocktaking Moment in Rome, the spotlight on global food security has never been more critical. Addressing the challenges of a burgeoning population and changing climate requires innovative solutions, and...
2023-07-26 19:18
1680
Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h
ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 AACC exhibition. The high-speed and fully automated analyzer has an ultra-high ...
2023-07-25 20:07
1418
Solar Biotech Acquires Noblegen
Solar Biotech Canada will transform consumer goods to ensure a sustainable future NORTON, Va. and PETERBOROUGH, ON, July 25, 2023 /PRNewswire/ -- Solar Biotech Inc., aNorton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, continues to build out its verti...
2023-07-25 19:42
1427
RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal
YANTAI, China, July 25, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-07-25 16:00
1523
Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market
Duopharma Biotech is a worldwide pioneer in the research and development of halal pharmaceuticals. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...
2023-07-25 14:00
1472
Fapon to Showcase Innovative Diagnostic and Biopharma Solutions at 2023 AACC Expo
ANAHEIM, Calif., July 24, 2023 /PRNewswire/ -- Fapon, a leading life science company, will showcase its latest innovations in in-vitro diagnostic and biopharma solutions at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo fromJuly 25 to 27. At t...
2023-07-24 21:58
1781
Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept
BRIDGEWATER, N.J. and BENGALURU, India, July 24, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion r...
2023-07-24 18:30
1467
BGI Genomics Global Cervical Cancer Survey Finds Young Women Have Higher Vaccination Rates but 43.5 percent Put off by Pap Smears
* Vaccination and Screening Form a Virtuous Cycle to Combat Cervical Cancer HONG KONG, July 24, 2023 /PRNewswire/ -- To further inform action to combat cervical cancer, the fourth most common cancer among women globally, BGI Genomics released its State of Cervical Cancer Awareness Report today....
2023-07-24 10:30
2299
Insilico Medicine Nominates Preclinical Candidate of Inhalation Solution for ISM001-055, the First Generative AI IPF Drug
* Insilico Medicine merges nebulizer device with AI-driven drug discovery; * Potential advantages for the inhalation solution include a smaller effective dose, larger safety window and reduced side effects; * As demonstrated in preclinical studies, the inhalation solution of ISM001-055 is we...
2023-07-22 14:37
3906
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023
GAITHERSBURG, Md., July 22, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...
2023-07-22 04:30
3419
Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA
SAN DIEGO, July 21, 2023 /PRNewswire/ -- Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosedFLT3-ITD positive acute myeloid leukemia (AML) who may...
2023-07-21 18:00
2561
Lynk Pharmaceuticals Announces First Atopic Dermatitis Patient Dosed with LNK01004 in Phase Ib Clinical Study
HANGZHOU, China, July 21, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has dosed the first patient with atopic dermatitis in a Phase Ib clinical trial of its innovative drug LNK0100...
2023-07-21 08:00
2518
Viva Biotech's Portfolio Company Riparian Pharmaceuticals Announces Exclusive License Agreement and Research Agreement with Pfizer for Novel Cardiovascular Programs
WATERTOWN, Mass., July 20, 2023 /PRNewswire/ -- Riparian Pharmaceuticals, a Viva Biotech portfolio company, is a biotechnology company focused on discovering novel therapeutics for cardiovascular diseases. Riparian today announced it has entered into an exclusive license agreement and research a...
2023-07-20 19:15
2178
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
